Categories AlphaGraphs, Earnings, Health Care

Key highlights from Moderna’s (MRNA) Q1 2023 earnings results

Moderna, Inc. (NASDAQ: MRNA) reported first quarter 2023 earnings results today.

Total revenue was $1.9 billion, compared to $6.1 billion in the same period a year ago, mainly due to a drop in sales of the company’s COVID-19 vaccines.

Product sales were $1.8 billion, down 69% compared to the prior-year period, driven mainly by lower sales volume.

Net income was $79 million, or $0.19 per share, compared to $3.7 billion, or $8.58 per share, last year.  

The company expects total product sales in the first half of 2023 to be approx. $2 billion. For the second quarter of 2023, sales are expected to be $0.2-0.3 billion.

Most Popular

Infographic: How Spotify (SPOT) performed in Q2 2024

Spotify Technology S.A. (NYSE: SPOT) reported its second quarter 2024 earnings results today. Total revenue increased 20% year-over-year to EUR3.8 billion. Net income attributable to owners of the parent was

Philip Morris (PM) Q2 2024 Earnings: Key financials and quarterly highlights

Philip Morris International Inc. (NYSE: PM) reported its second quarter 2024 earnings results today. Net revenues increased 5.6% year-over-year to $9.5 billion. On an organic basis, revenues grew 9.6%. Net

LMT Earnings: Highlights of Lockheed Martin’s Q2 2024 financial results

Lockheed Martin Corporation (NYSE: LMT) Tuesday reported a year-over-year increase in net sales for the second quarter of 2024. The management raised its fiscal 2024 guidance. The aerospace company reported

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top